A Phase II Trial of FM (Oral Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Follicular Lymphoma (FL) Patients.
暂无分享，去创建一个
M. Voso | S. Fanti | P. Zinzani | P. Castellucci | L. Rigacci | A. Pulsoni | F. Zaja | A. Fabbri | M. Balocco | A. Zaccaria | M. Tani | P. Fattori | A. D. Renzo | A. Perrotti | M. Cabras | P. Gentilini | L. Guardigni